Article

Diagnostic instrumentation advances benefit refractive surgeons, patients

Innovations in diagnostic technology have implications for improving the screening and follow-up of refractive surgery patients. An ophthalmologist reviews equipment and features that are newly available and others that are on the near horizon.

Key Points

Dr. Reinstein provided an update on some of the most recent advances in diagnostic instrumentation that are relevant to refractive surgeons, focusing on improved methods for measuring IOP after refractive surgery, instrumentation for measuring quality of vision, developments in corneal topography, and new indices for keratoconus screening. He is the medical director of the London Vision Clinic, London, and assistant professor of clinical ophthalmology, Weill Medical College, Cornell University, New York.

Measuring IOP

The CH-measuring instrument is a modified air-puff tonometer that provides an IOP measurement that is virtually independent of corneal thickness.

"While it does not directly measure pressure in the eye, [this instrument] does a very good job of approximating the value," Dr. Reinstein told Ophthalmology Times.

In addition to its role for IOP measurement, the device provides two measures of the biomechanical properties of the cornea: CH and the corneal resistance factor (CRF). These indices are calculated by analyzing the signal derived from the inward and outward applanation events induced by the air-puff.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.